首站-论文投稿智能助手
典型文献
SOX5 promotes cell growth and migration through modulating DNMT1/p21 pathway in bladder cancer
文献摘要:
Bladder cancer(BC)is one of the most prevalent and life-threatening cancers among the male population world-wide.Sex determining region Y-box protein 5(SOX5)plays important roles in a variety of human cancers.However,little research has been conducted on the function and underlying mechanism of SOX5 in BC.In the present study,we first reveal the increased expression of SOX5 in BC tissues and in vitro cells lines.Second,we discover that inhibition of SOX5 inhibits cell growth and migration but promotes cell apoptosis.Meanwhile,ectopic SOX5 expression stimulates cell growth and migration in BC cells.Then,we show that suppressing SOX5 inhibits the expression of DNA methyltransferase 1(DNMT1),and that overexpressing DNMT1 alleviates the cell progress of BC cells inhibited by SOX5.Furthermore,we demonstrate that DNMT1 inhibits p21 expression by affecting DNA methylation of the p21 promoter.Collectively,we demonstrate that SOX5 exerts its functions in BC cells by mod-ulating the SOX5/DNMT1/p21 pathway.Finally,we demonstrate that SOX5 knockdown inhibits xenograft tumor growth in vivo.In conclusion,our study elucidates the oncogenic role of SOX5 and its underlying molecular mechanism in BC,and reveals a novel pathway which has the potential to serve as a diagnostic biomarker and therapeutic target for BC.
文献关键词:
作者姓名:
Longxiang Wu;Zhongqing Yang;Guoyu Dai;Benyi Fan;Junbin Yuan;Yalin Liu;Peihua Liu;Zhenyu Ou
作者机构:
Department of Urology,Xiangya Hospital,Central South University,Changsha 410008,China;National Clinical Research Center for Geriatric Disorders,Xiangya Hospital,Central South University,Changsha 410008,China;Xiangya School of Medicine,Central South University,Changsha 410008,China
引用格式:
[1]Longxiang Wu;Zhongqing Yang;Guoyu Dai;Benyi Fan;Junbin Yuan;Yalin Liu;Peihua Liu;Zhenyu Ou-.SOX5 promotes cell growth and migration through modulating DNMT1/p21 pathway in bladder cancer)[J].生物化学与生物物理学报(英文版),2022(07):987-998
A类:
B类:
SOX5,promotes,growth,migration,through,modulating,DNMT1,p21,pathway,bladder,Bladder,BC,one,most,prevalent,life,threatening,cancers,among,male,population,world,wide,Sex,determining,region,box,protein,plays,important,roles,variety,human,However,little,research,has,been,conducted,underlying,mechanism,In,present,study,first,increased,expression,tissues,vitro,cells,lines,Second,discover,that,inhibition,inhibits,but,apoptosis,Meanwhile,ectopic,stimulates,Then,show,suppressing,methyltransferase,overexpressing,alleviates,progress,inhibited,by,Furthermore,demonstrate,affecting,methylation,promoter,Collectively,exerts,functions,Finally,knockdown,xenograft,tumor,vivo,conclusion,our,elucidates,oncogenic,molecular,reveals,novel,which,potential,serve,diagnostic,biomarker,therapeutic,target
AB值:
0.499299
相似文献
N6?methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance
Xian Lin;Feng Wang;Jian Chen;Jing Liu;Yi?Bin Lin;Li Li;Chuan?Ben Chen;Qin Xu-Departments of Gynecology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Department of Radiation Oncology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Shenzhen Key Laboratory of Immunity and Inflammatory Diseases,Peking University Shenzhen Hospital,Shenzhen Peking University?the Hong Kong University of Science and Technology Medical Center,Shenzhen 518036,Guangdong,China;Outpatient Department,Fujian Hospital of People's Armed Police,Fujian Medical University,Fuzhou 350014,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis
Fang Wang;Jia-nan Wang;Xiao-yan He;Xiao-guo Suo;Chao Li;Wei-jian Ni;Yu-ting Cai;Yuan He;Xin-yun Fang;Yu-hang Dong;Tian Xing;Ya-ru Yang;Feng Zhang;Xiang Zhong;Hong-mei Zang;Ming-ming Liu;Jun Li;Xiao-ming Meng;Juan Jin-Inflammation and Immune Mediated Diseases Laboratory of Anhui Province,Anhui Institute of Innovative Drugs,School of Pharmacy,Anhui Medical University,The Key Laboratory of Anti-inflammatory of Immune Medicines,Ministry of Education,Hefei 230032,China;Department of Pharmacy,Anhui Provincial Hospital,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei 230001,China;Hospital of Stomatology,Anhui Medical University,Key Laboratory of Oral Diseases Research of Anhui Province,Hefei 230032,China;Department of Pharmacy,Changzheng Hospital,Naval Medical University,Shanghai 200003,China;Department of Nephrology,Sichuan Academy of Medical Sciences&Sichuan Provincial People's Hospital,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610072,China;School of Basic Medical Sciences,Anhui Medical University,Hefei 230032,China
Identification of HMGCR as the anticancer target of physapubenolide against melanoma cells by in silico target prediction
Hai-yan Wang;Pian Yu;Xi-sha Chen;Hui Wei;Shi-jie Cao;Meng Zhang;Yi Zhang;Yong-guang Tao;Dong-sheng Cao;Feng Qiu;Yan Cheng-Department of Pharmacy,The Second Xiangya Hospital,Central South University,Changsha 410011,China;Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug,Changsha 410011,China;Xiangya School of Pharmaceutical Sciences,Central South University,Changsha 410008,China;School of Chinese Materia Medica and Tianjin State Key Laboratory of Modern Chinese Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;Department of Pharmacology,College of Pharmaceutical Sciences,Soochow University,Suzhou 215031,China;Key laboratory of Carcinogenesis and Cancer Invasion,Ministry of Education,Department of Pathology,Xiangya Hospital,School of Basic Medicine,Central South University,Changsha 410078,China;NHC Key laboratory of Carcinogenesis,Cancer Research Institute,Central South University,Changsha 410078,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。